Opportunities and challenges encountered in managing cervical cancer during the coronavirus disease 2019 pandemic

The COVID-19 pandemic, while putting pressure on the global healthcare system, has had a significant impact on the prevention, diagnosis, and treatment of cervical cancer. The aim of this study is to provide an overview of the challenges and opportunities presented to cervical cancer during the COVI...

Full description

Saved in:
Bibliographic Details
Published in:Infectious agents and cancer 2024-08, Vol.19 (1), p.41-7, Article 41
Main Authors: Dong, Shixiang, Wang, Yankui, Ding, Yu
Format: Article
Language:English
Subjects:
Anxiety
Cancer
Cancer screening
Cancer therapies
Care and treatment
Cervical cancer
Coronaviruses
COVID-19
COVID-19 vaccines
Developing countries
Diagnosis
Disease management
Disease prevention
Diseases
Eradication
Global health
Health aspects
Hospitals
HPV
Human papillomavirus
Immunization
LDCs
Medical screening
Oncology, Experimental
Pandemics
Papillomavirus infections
Patients
Prevention
Review
Severe acute respiratory syndrome coronavirus 2
Testing laboratories
Womens health
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c445t-49d8500a2df774b6a35139163dad1693cba1c1462d9dd4723f24227ba7e7d4f83
container_end_page 7
container_issue 1
container_start_page 41
container_title Infectious agents and cancer
container_volume 19
creator Dong, Shixiang
Wang, Yankui
Ding, Yu
description The COVID-19 pandemic, while putting pressure on the global healthcare system, has had a significant impact on the prevention, diagnosis, and treatment of cervical cancer. The aim of this study is to provide an overview of the challenges and opportunities presented to cervical cancer during the COVID-19 pandemic and to provide lessons for better coping with cervical cancer in future pandemics. The search terms included the following: SARS-CoV-2 and/or COVID-19 with cervical cancer and HPV. The initial literature search began on June 1, 2022 and ended on March 1, 2023. COVID-19 has hindered the cervical cancer screening, delayed the diagnosis and treatment of cervical cancer, increased the public's anxiety, and negatively affected the management of cervical cancer. However, the occurrence of COVID-19 pandemic has promoted the development of new human papillomavirus (HPV) tests and improved the rates of HPV self-sampling, offering a small window of opportunity to eliminate cervical cancer. In the next few years, the COVID-19 pandemic will come to an end, and the eradication of cervical cancer should always be carried out. We should draw lessons and experience from this global pandemic, and make efforts for the subsequent eradication of cervical cancer.
doi_str_mv 10.1186/s13027-024-00594-3
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_1522c50f23ea4928becb79a6e955e585</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A808377400</galeid><doaj_id>oai_doaj_org_article_1522c50f23ea4928becb79a6e955e585</doaj_id><sourcerecordid>A808377400</sourcerecordid><originalsourceid>FETCH-LOGICAL-c445t-49d8500a2df774b6a35139163dad1693cba1c1462d9dd4723f24227ba7e7d4f83</originalsourceid><addsrcrecordid>eNptUk1v1DAQjRCIloU_wAFF4sIlxZ-JfUJVxUelSr3A2ZrYk6xXWXtrJyv13-PtltJFyAePx-89z4xfVb2n5IJS1X7OlBPWNYSJhhCpRcNfVOe0k6TRvFMvn8Vn1ZucN4QIxZR6XZ1xzSgRkp1Xd7e7XUzzEvzsMdcQXG3XME0YxnLEYOMSZkzoah_qLQQYfRhri2nvLUy1hVDi2i3pkJ7XWNuYYoC9T0uunc8IGWtGqK53RRu33r6tXg0wZXz3uK-qX9--_rz60dzcfr--urxprBByboR2ShICzA1dJ_oWuKRc05Y7cLTV3PZALRUtc9o50TE-MMFY10OHnROD4qvq-qjrImzMLvktpHsTwZuHREyjgTR7O6GhkjErycA4gtBM9Wj7TkOLWkqUShatL0et3dJv0VkMc4LpRPT0Jvi1GePeUMpbSkvlq-rTo0KKdwvm2Wx9tjhNEDAu2XCitSKMd7xAP_4D3cQlhTIrwylhkkhK9V_UCKUDH4ZYHrYHUXOpiOJlaIQU1MV_UGU9fEUMOPiSPyGwI8GmmHPC4alJSszBdeboOlNcZx5cZw4Vf3g-nifKH5vx31ir0Zs</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3102505119</pqid></control><display><type>article</type><title>Opportunities and challenges encountered in managing cervical cancer during the coronavirus disease 2019 pandemic</title><source>Publicly Available Content Database</source><source>PubMed Central</source><source>Coronavirus Research Database</source><creator>Dong, Shixiang ; Wang, Yankui ; Ding, Yu</creator><creatorcontrib>Dong, Shixiang ; Wang, Yankui ; Ding, Yu</creatorcontrib><description>The COVID-19 pandemic, while putting pressure on the global healthcare system, has had a significant impact on the prevention, diagnosis, and treatment of cervical cancer. The aim of this study is to provide an overview of the challenges and opportunities presented to cervical cancer during the COVID-19 pandemic and to provide lessons for better coping with cervical cancer in future pandemics. The search terms included the following: SARS-CoV-2 and/or COVID-19 with cervical cancer and HPV. The initial literature search began on June 1, 2022 and ended on March 1, 2023. COVID-19 has hindered the cervical cancer screening, delayed the diagnosis and treatment of cervical cancer, increased the public's anxiety, and negatively affected the management of cervical cancer. However, the occurrence of COVID-19 pandemic has promoted the development of new human papillomavirus (HPV) tests and improved the rates of HPV self-sampling, offering a small window of opportunity to eliminate cervical cancer. In the next few years, the COVID-19 pandemic will come to an end, and the eradication of cervical cancer should always be carried out. We should draw lessons and experience from this global pandemic, and make efforts for the subsequent eradication of cervical cancer.</description><identifier>ISSN: 1750-9378</identifier><identifier>EISSN: 1750-9378</identifier><identifier>DOI: 10.1186/s13027-024-00594-3</identifier><identifier>PMID: 39210452</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Anxiety ; Cancer ; Cancer screening ; Cancer therapies ; Care and treatment ; Cervical cancer ; Coronaviruses ; COVID-19 ; COVID-19 vaccines ; Developing countries ; Diagnosis ; Disease management ; Disease prevention ; Diseases ; Eradication ; Global health ; Health aspects ; Hospitals ; HPV ; Human papillomavirus ; Immunization ; LDCs ; Medical screening ; Oncology, Experimental ; Pandemics ; Papillomavirus infections ; Patients ; Prevention ; Review ; Severe acute respiratory syndrome coronavirus 2 ; Testing laboratories ; Womens health</subject><ispartof>Infectious agents and cancer, 2024-08, Vol.19 (1), p.41-7, Article 41</ispartof><rights>2024. The Author(s).</rights><rights>COPYRIGHT 2024 BioMed Central Ltd.</rights><rights>2024. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2024 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c445t-49d8500a2df774b6a35139163dad1693cba1c1462d9dd4723f24227ba7e7d4f83</cites><orcidid>0000-0001-6161-8304</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11361151/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3102505119?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25732,27903,27904,36991,36992,38495,43874,44569,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39210452$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dong, Shixiang</creatorcontrib><creatorcontrib>Wang, Yankui</creatorcontrib><creatorcontrib>Ding, Yu</creatorcontrib><title>Opportunities and challenges encountered in managing cervical cancer during the coronavirus disease 2019 pandemic</title><title>Infectious agents and cancer</title><addtitle>Infect Agent Cancer</addtitle><description>The COVID-19 pandemic, while putting pressure on the global healthcare system, has had a significant impact on the prevention, diagnosis, and treatment of cervical cancer. The aim of this study is to provide an overview of the challenges and opportunities presented to cervical cancer during the COVID-19 pandemic and to provide lessons for better coping with cervical cancer in future pandemics. The search terms included the following: SARS-CoV-2 and/or COVID-19 with cervical cancer and HPV. The initial literature search began on June 1, 2022 and ended on March 1, 2023. COVID-19 has hindered the cervical cancer screening, delayed the diagnosis and treatment of cervical cancer, increased the public's anxiety, and negatively affected the management of cervical cancer. However, the occurrence of COVID-19 pandemic has promoted the development of new human papillomavirus (HPV) tests and improved the rates of HPV self-sampling, offering a small window of opportunity to eliminate cervical cancer. In the next few years, the COVID-19 pandemic will come to an end, and the eradication of cervical cancer should always be carried out. We should draw lessons and experience from this global pandemic, and make efforts for the subsequent eradication of cervical cancer.</description><subject>Anxiety</subject><subject>Cancer</subject><subject>Cancer screening</subject><subject>Cancer therapies</subject><subject>Care and treatment</subject><subject>Cervical cancer</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 vaccines</subject><subject>Developing countries</subject><subject>Diagnosis</subject><subject>Disease management</subject><subject>Disease prevention</subject><subject>Diseases</subject><subject>Eradication</subject><subject>Global health</subject><subject>Health aspects</subject><subject>Hospitals</subject><subject>HPV</subject><subject>Human papillomavirus</subject><subject>Immunization</subject><subject>LDCs</subject><subject>Medical screening</subject><subject>Oncology, Experimental</subject><subject>Pandemics</subject><subject>Papillomavirus infections</subject><subject>Patients</subject><subject>Prevention</subject><subject>Review</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Testing laboratories</subject><subject>Womens health</subject><issn>1750-9378</issn><issn>1750-9378</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptUk1v1DAQjRCIloU_wAFF4sIlxZ-JfUJVxUelSr3A2ZrYk6xXWXtrJyv13-PtltJFyAePx-89z4xfVb2n5IJS1X7OlBPWNYSJhhCpRcNfVOe0k6TRvFMvn8Vn1ZucN4QIxZR6XZ1xzSgRkp1Xd7e7XUzzEvzsMdcQXG3XME0YxnLEYOMSZkzoah_qLQQYfRhri2nvLUy1hVDi2i3pkJ7XWNuYYoC9T0uunc8IGWtGqK53RRu33r6tXg0wZXz3uK-qX9--_rz60dzcfr--urxprBByboR2ShICzA1dJ_oWuKRc05Y7cLTV3PZALRUtc9o50TE-MMFY10OHnROD4qvq-qjrImzMLvktpHsTwZuHREyjgTR7O6GhkjErycA4gtBM9Wj7TkOLWkqUShatL0et3dJv0VkMc4LpRPT0Jvi1GePeUMpbSkvlq-rTo0KKdwvm2Wx9tjhNEDAu2XCitSKMd7xAP_4D3cQlhTIrwylhkkhK9V_UCKUDH4ZYHrYHUXOpiOJlaIQU1MV_UGU9fEUMOPiSPyGwI8GmmHPC4alJSszBdeboOlNcZx5cZw4Vf3g-nifKH5vx31ir0Zs</recordid><startdate>20240829</startdate><enddate>20240829</enddate><creator>Dong, Shixiang</creator><creator>Wang, Yankui</creator><creator>Ding, Yu</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-6161-8304</orcidid></search><sort><creationdate>20240829</creationdate><title>Opportunities and challenges encountered in managing cervical cancer during the coronavirus disease 2019 pandemic</title><author>Dong, Shixiang ; Wang, Yankui ; Ding, Yu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c445t-49d8500a2df774b6a35139163dad1693cba1c1462d9dd4723f24227ba7e7d4f83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Anxiety</topic><topic>Cancer</topic><topic>Cancer screening</topic><topic>Cancer therapies</topic><topic>Care and treatment</topic><topic>Cervical cancer</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 vaccines</topic><topic>Developing countries</topic><topic>Diagnosis</topic><topic>Disease management</topic><topic>Disease prevention</topic><topic>Diseases</topic><topic>Eradication</topic><topic>Global health</topic><topic>Health aspects</topic><topic>Hospitals</topic><topic>HPV</topic><topic>Human papillomavirus</topic><topic>Immunization</topic><topic>LDCs</topic><topic>Medical screening</topic><topic>Oncology, Experimental</topic><topic>Pandemics</topic><topic>Papillomavirus infections</topic><topic>Patients</topic><topic>Prevention</topic><topic>Review</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Testing laboratories</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dong, Shixiang</creatorcontrib><creatorcontrib>Wang, Yankui</creatorcontrib><creatorcontrib>Ding, Yu</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Infectious agents and cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dong, Shixiang</au><au>Wang, Yankui</au><au>Ding, Yu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Opportunities and challenges encountered in managing cervical cancer during the coronavirus disease 2019 pandemic</atitle><jtitle>Infectious agents and cancer</jtitle><addtitle>Infect Agent Cancer</addtitle><date>2024-08-29</date><risdate>2024</risdate><volume>19</volume><issue>1</issue><spage>41</spage><epage>7</epage><pages>41-7</pages><artnum>41</artnum><issn>1750-9378</issn><eissn>1750-9378</eissn><abstract>The COVID-19 pandemic, while putting pressure on the global healthcare system, has had a significant impact on the prevention, diagnosis, and treatment of cervical cancer. The aim of this study is to provide an overview of the challenges and opportunities presented to cervical cancer during the COVID-19 pandemic and to provide lessons for better coping with cervical cancer in future pandemics. The search terms included the following: SARS-CoV-2 and/or COVID-19 with cervical cancer and HPV. The initial literature search began on June 1, 2022 and ended on March 1, 2023. COVID-19 has hindered the cervical cancer screening, delayed the diagnosis and treatment of cervical cancer, increased the public's anxiety, and negatively affected the management of cervical cancer. However, the occurrence of COVID-19 pandemic has promoted the development of new human papillomavirus (HPV) tests and improved the rates of HPV self-sampling, offering a small window of opportunity to eliminate cervical cancer. In the next few years, the COVID-19 pandemic will come to an end, and the eradication of cervical cancer should always be carried out. We should draw lessons and experience from this global pandemic, and make efforts for the subsequent eradication of cervical cancer.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>39210452</pmid><doi>10.1186/s13027-024-00594-3</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0001-6161-8304</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1750-9378
ispartof Infectious agents and cancer, 2024-08, Vol.19 (1), p.41-7, Article 41
issn 1750-9378
1750-9378
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_1522c50f23ea4928becb79a6e955e585
source Publicly Available Content Database; PubMed Central; Coronavirus Research Database
subjects Anxiety
Cancer
Cancer screening
Cancer therapies
Care and treatment
Cervical cancer
Coronaviruses
COVID-19
COVID-19 vaccines
Developing countries
Diagnosis
Disease management
Disease prevention
Diseases
Eradication
Global health
Health aspects
Hospitals
HPV
Human papillomavirus
Immunization
LDCs
Medical screening
Oncology, Experimental
Pandemics
Papillomavirus infections
Patients
Prevention
Review
Severe acute respiratory syndrome coronavirus 2
Testing laboratories
Womens health
title Opportunities and challenges encountered in managing cervical cancer during the coronavirus disease 2019 pandemic
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T20%3A28%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Opportunities%20and%20challenges%20encountered%20in%20managing%20cervical%20cancer%20during%20the%20coronavirus%20disease%202019%20pandemic&rft.jtitle=Infectious%20agents%20and%20cancer&rft.au=Dong,%20Shixiang&rft.date=2024-08-29&rft.volume=19&rft.issue=1&rft.spage=41&rft.epage=7&rft.pages=41-7&rft.artnum=41&rft.issn=1750-9378&rft.eissn=1750-9378&rft_id=info:doi/10.1186/s13027-024-00594-3&rft_dat=%3Cgale_doaj_%3EA808377400%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c445t-49d8500a2df774b6a35139163dad1693cba1c1462d9dd4723f24227ba7e7d4f83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3102505119&rft_id=info:pmid/39210452&rft_galeid=A808377400&rfr_iscdi=true